Zacks Research Cuts Earnings Estimates for Gilead Sciences
Stock analysts at Zacks Research reduced their Q3 2026 earnings per share estimates for shares of Gilead Sciences in a research report issued on Tuesday, February 25th. Zacks Research analyst E. Bagri ...
Giving an old malaria drug new life
Working with a contract drug manufacturing and testing firm in Britain, 25 to 30 healthy volunteers are starting to receive ...